Your browser doesn't support javascript.
loading
Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial.
Yuan, Jing-Jing; Ding, Jian-Wu; Li, Jin-Wei; Hu, Rong-Huan; Gong, Dan; Hu, Jia-Li; Zhu, Kai-Bin; Liu, Yan; Ding, Yu-Hai; Wei, Jia-Wang; Zeng, Jian-Lun; Lu, Zhi-Bing; Yin, Wei-Hua; Ai, Su-Fen; Zha, Guo-Hua; Zhang, Zhi-Lin; Zou, Rui; Zeng, Lei.
Affiliation
  • Yuan JJ; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Ding JW; The First Clinical Medical College, Nanchang University, Nanchang, China.
  • Li JW; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Hu RH; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Gong D; Department of Radiotherapy, Ganzhou Cancer Hospital, Ganzhou, China.
  • Hu JL; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Zhu KB; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Liu Y; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Ding YH; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Wei JW; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Zeng JL; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Lu ZB; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Yin WH; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Ai SF; Department Of Oncology, Nanchang University Second Affiliated Hospital, Nanchang, China.
  • Zha GH; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, China.
  • Zhang ZL; Department of Oncology, Ganzhou People's Hospital, Ganzhou, Jiangxi, China.
  • Zou R; Department of Oncology, Ganzhou People's Hospital, Ganzhou, Jiangxi, China.
  • Zeng L; Department of Oncology, Pingxiang People's Hospital, Pingxiang, China.
BMJ Open ; 12(8): e051594, 2022 08 25.
Article in En | MEDLINE | ID: mdl-36008072
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMJ Open Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMJ Open Year: 2022 Type: Article Affiliation country: China